Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
- APPROACH Study Group
Producción científica: Article › revisión exhaustiva
90
El enlace se abre en una pestaña nueva
Citas
(Scopus)